Global Adiponectin Testing Market: Snapshot
Adioponectin has shown substantial clinical potential as an adipocyte-derived protein in the pathophysiology of the metabolic diseases and coronary artery disease. Higher levels of circulating adiponectin is linked with high risk of adverse cardiovascular events, pre-diabetes, and metabolic syndrome. Several studies done on animal models have highlighted these findings, a key evolutionary factor for the adiponectin testing market. The health care industry has also focused form benefitting from the testing on animals where anti-inflammatory, antiatherogenic, cardiomyocyte-protective, and insulin-sensitizing properties of the hormone is utilized.
Over the recent decade, substantial efforts have been made in exploring the use of adiponectin testing as a potential biomarker in insulin sensitivity and obesity in human patients. Still, the test isn’t considered as a key determinant in conclusively identifying metabolic disease risks in patients. However, in recent years, the testing has growing in application for livestock.
The key application areas of the adiponectin testing are for diagnostics and research. Methods used comprise enzyme linked immunosorbent assay (ELISA) and enzyme immunoassay kits.
Need an overview of the report on Adiponectin Testing market? Ask for the brochure here
Global Adiponectin Testing Market: Growth Dynamics
The drive for the adiponectin testing market stems from the growing potential of adipose-derived products as a drug target to treat as well as prevent cardiometabolic diseases. New prospects have emerged in the market from growing body of research on understanding the pathophysiology of metabolic syndrome. The syndrome has evoked intense concern across worldwide healthcare systems. The marked mortality of diseases caused by this syndrome, such as non-alcoholic fatty liver disease (NAFLD), cardiovascular disease (CVD), and type 2 diabetes, has augmented the scope of the adiponectin testing market.
Drug makers in recent years have been focusing on new drug targets for insulin resistance (IR)-related metabolic disorders. This has also propelled industry interest in adiponectin testing. On the other hand, the growing demand for population for the diagnosis of hypoadiponectinemia has bolstered the prospects of the adiponectin testing market. Growing epidemic of obese population of all ages has also been fueling clinical studies on adiponectin levels in the body.
Looking for exclusive market insights from business experts? Request a Custom Report here
Global Adiponectin Testing Market: Notable Developments
The advent of functional food ingredients that claim to improve adipocyte health and adiponectin metabolism has expanded the avenue for market players. Over the years, studies that aims at the meta-analysis of the hormone as a biomarker for the detection of metabolic syndrome has gained steam, thereby boosting the adiponectin testing market. Advances in laboratory infrastructure for such tests have also propelled investments in the adiponectin testing market.
Manufacturers of testing kits in adiponectin testing market are striving to expand their product portfolio, and many have entered into new product launches and acquisitions. They have also garnered scientific backing based on meta-analysis of the clinical potential of adiponectin. Further, they have been gaining from epidemiology surveys with the objective of upholding the diagnostic potential of products in adiponectin testing market.
Some of the prominent players in the adiponectin testing market are:
- Thermo fisher Scientific Inc.
- Biorad laboratories
- Merck KGaA
- Boster Biological Technology
- Eagle Biosciences
Global Adiponectin Testing Market: Regional Assessment
The adiponectin market has been witnessing sizable avenues in the regions of North America, Europe, Latin America, Oceania, Asia, and the Middle East and Africa. Of these, North America has been contributing to the growth of the global market considerably. The growth can be apportioned to the growing potential of adipose-based products in reinforcing the drug pipelines for treating metabolic syndrome. Meanwhile, Asian countries with a burgeoning medical tourism has seen a promising potential.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.